A detailed history of Geode Capital Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 472,381 shares of FLGT stock, worth $9.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
472,381
Previous 462,760 2.08%
Holding current value
$9.44 Million
Previous $13.4 Million 23.38%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$21.55 - $29.29 $207,332 - $281,799
9,621 Added 2.08%
472,381 $10.3 Million
Q4 2023

Feb 13, 2024

BUY
$23.64 - $30.27 $474,454 - $607,518
20,070 Added 4.53%
462,760 $13.4 Million
Q3 2023

Nov 13, 2023

BUY
$26.74 - $40.81 $807,093 - $1.23 Million
30,183 Added 7.32%
442,690 $11.8 Million
Q2 2023

Aug 11, 2023

BUY
$28.52 - $40.7 $223,682 - $319,210
7,843 Added 1.94%
412,507 $15.3 Million
Q1 2023

May 15, 2023

BUY
$29.39 - $36.27 $268,448 - $331,290
9,134 Added 2.31%
404,664 $12.6 Million
Q4 2022

Feb 13, 2023

SELL
$29.23 - $40.28 $18,999 - $26,182
-650 Reduced 0.16%
395,530 $11.8 Million
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $501,378 - $842,770
13,222 Added 3.45%
396,180 $15.1 Million
Q2 2022

Aug 12, 2022

BUY
$47.98 - $62.75 $336,531 - $440,128
7,014 Added 1.87%
382,958 $20.9 Million
Q1 2022

May 13, 2022

BUY
$49.85 - $96.11 $86,390 - $166,558
1,733 Added 0.46%
375,944 $23.5 Million
Q4 2021

Feb 11, 2022

BUY
$77.3 - $105.0 $1.11 Million - $1.51 Million
14,369 Added 3.99%
374,211 $37.6 Million
Q3 2021

Nov 12, 2021

BUY
$74.87 - $110.87 $1.79 Million - $2.66 Million
23,963 Added 7.13%
359,842 $32.4 Million
Q2 2021

Aug 13, 2021

BUY
$66.8 - $100.45 $4.54 Million - $6.83 Million
67,971 Added 25.37%
335,879 $31 Million
Q1 2021

May 12, 2021

BUY
$59.3 - $183.85 $4.25 Million - $13.2 Million
71,596 Added 36.47%
267,908 $25.9 Million
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $1.27 Million - $2.13 Million
40,933 Added 26.34%
196,312 $10.2 Million
Q3 2020

Nov 13, 2020

SELL
$15.89 - $50.51 $13,633 - $43,337
-858 Reduced 0.55%
155,379 $6.22 Million
Q2 2020

Aug 13, 2020

BUY
$8.89 - $18.28 $525,674 - $1.08 Million
59,131 Added 60.89%
156,237 $2.5 Million
Q1 2020

May 14, 2020

BUY
$6.75 - $19.75 $22,362 - $65,431
3,313 Added 3.53%
97,106 $1.04 Million
Q4 2019

Feb 13, 2020

BUY
$9.29 - $15.82 $585,455 - $996,976
63,020 Added 204.79%
93,793 $1.21 Million
Q3 2019

Nov 12, 2019

BUY
$5.96 - $12.81 $183,407 - $394,202
30,773 New
30,773 $319,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $605M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.